Document Classification

Section Type: RESULTS

Text: Terbutaline ingestion raised plasma glucose minimally (e. g., to 6. 3 + / - 0. 3 mM, P = 0. 0133) in nondiabetic subjects but substantially, to 10. 2 + / - 1. 0 (terbutaline 2. 5 mg, P = 0. 0078) and 14. 0 + / - 0. 6 mM (terbutaline 5. 0 mg, P = 0. 0001), in IDDM patients ; subcutaneous terbutaline raised plasma glucose (to a peak of 10. 3 + / - 0. 7 mM, P = 0. 0017) with an initial effect within 10 min, but inhaled terbutaline did so more slowly.